{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:57:11Z","timestamp":1767135431833,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":71,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003825.pub3","type":"reference-entry","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T11:26:10Z","timestamp":1344425170000},"source":"Crossref","is-referenced-by-count":4,"title":["Blood pressure lowering efficacy of loop diuretics for primary hypertension"],"prefix":"10.1002","author":[{"given":"Vijaya M","family":"Musini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pouria","family":"Rezapour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Bassett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciprian D","family":"Jauca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,8,15]]},"reference":[{"key":"10.1002\/14651858.CD003825.pub3-BIB1|cit1","first-page":"101","article-title":"Efficacy and tolerance of cicletanine in arterial hypertension of the elderly","volume":"44","author":"Bodak","year":"1989","journal-title":"Therapie"},{"issue":"11","key":"10.1002\/14651858.CD003825.pub3-BIB2|cit2","first-page":"377","article-title":"Duration of Antihypertensive Effectiveness during Therapy with Cicletanine in Ambulatory 24-h Blood Pressure Measurement","volume":"26","author":"Gotzen","year":"1994","journal-title":"Herz\/Kreisl"},{"key":"10.1002\/14651858.CD003825.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/0002-9149(93)90882-D","article-title":"Usefulness of pirentanide plus ramipril for systemic hypertension: A multicenter trial","volume":"72","author":"Homuth","year":"1993","journal-title":"The American Jornal of Cardiology"},{"key":"10.1002\/14651858.CD003825.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/j.1875-9114.1984.tb03375.x","article-title":"Antihypertensive and biochemical effects of indacrinone enantiomers","volume":"4","author":"Jain","year":"1984","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1002\/14651858.CD003825.pub3-BIB5|cit5","first-page":"263","article-title":"Clinical and hemodynamic effects of etozolin in essential hypertension: A double blind controlled trial","volume":"45","author":"Licata","year":"1989","journal-title":"Current Therapeutic Research"},{"issue":"3","key":"10.1002\/14651858.CD003825.pub3-BIB6|cit6","first-page":"545","article-title":"Metabolic effects of furosemide and the combination of furosemide and triamterene","volume":"37","author":"Perola","year":"1985","journal-title":"Current Therapeutic Reserach"},{"key":"10.1002\/14651858.CD003825.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/030006058201000401","article-title":"Experience with once daily and twice daily slow release frusemide in hypertension","volume":"10","author":"Vadasz","year":"1982","journal-title":"J Int Med Res"},{"issue":"5","key":"10.1002\/14651858.CD003825.pub3-BIB8|cit8","first-page":"385","article-title":"Pirentanide in the treatment of essential hypertension. A double blind comparison versus placebo","volume":"XII","author":"Verho","year":"1986","journal-title":"Drugs Exptl. Clin. Res."},{"key":"10.1002\/14651858.CD003825.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/archinte.1971.00310170142020","article-title":"Furosemide in essential hypertension. A ststistical analysis of three double blind stuides","volume":"127","author":"Wertheimer","year":"1971","journal-title":"Archives Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003825.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1185\/03007998109114270","article-title":"Comparison of antihypertensive activities of xipamid and chlorthalidone: a double blind randomized cross over trial","volume":"7","author":"Bonaduce","year":"1981","journal-title":"Current Medical reserach and Opinion"},{"key":"10.1002\/14651858.CD003825.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/030006058401200203","article-title":"A double blind multicentre study of pirentanide and hydrochlorthiazide in patients with essentail hypertension","volume":"12","author":"Buckert","year":"1984","journal-title":"J Int Med Res"},{"key":"10.1002\/14651858.CD003825.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/archinte.158.13.1461","article-title":"Fluctuations in blood lipid levels during furosemide therapy","volume":"158","author":"Campbell","year":"1998","journal-title":"Archives of Internal medicine"},{"key":"10.1002\/14651858.CD003825.pub3-BIB13|cit13","first-page":"169","article-title":"The Eurieve study: contrasting effect of pirentanide and thiazides in mild to moderate hypertension","volume":"52","author":"Charossoney","year":"1997","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD003825.pub3-BIB14|cit14","first-page":"1293","article-title":"Efficacy and tolerance of cicletanine added to a previous beta blocking tehrapy in essential hypertensive patients","volume":"82","author":"Clerson","year":"1989","journal-title":"Arch Mal Coeur"},{"key":"10.1002\/14651858.CD003825.pub3-BIB15|cit15","first-page":"A97 ST-Evaluati","article-title":"Evaluation of the effects of prolongedrelease torasemide versus furosemide on myocardial fibrosis (Torafic Study): Design and baseline characteristics","volume":"1)","author":"Coca","year":"2009","journal-title":"Journal of Clinical Hypertension"},{"key":"10.1002\/14651858.CD003825.pub3-BIB16|cit16","doi-asserted-by":"crossref","first-page":"F273-F8 ST - Va","DOI":"10.1152\/ajprenal.00195.2005","article-title":"Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure","volume":"290","author":"Costello-Boerrigter","year":"2006","journal-title":"American Journal of Physiology - Renal Physiology"},{"key":"10.1002\/14651858.CD003825.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"897-904 ST - TO","DOI":"10.1586\/erc.09.74","article-title":"TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure","volume":"7","author":"Diez","year":"2009","journal-title":"Expert Review of Cardiovascular Therapy"},{"issue":"6","key":"10.1002\/14651858.CD003825.pub3-BIB18|cit18","first-page":"1044","article-title":"The hemodynamic effect of etozolin in teh treatment of hypertension","volume":"48","author":"Somma","year":"1990","journal-title":"Current therapeutic Research"},{"key":"10.1002\/14651858.CD003825.pub3-BIB19|cit19","doi-asserted-by":"crossref","unstructured":"Drolet D W Coar W Boinpally R Walker G Effect On Peripheral Blood Pressure Of A Single Oral Dose Of Cicletanine HCl Alone Or In The Presence Of Steady State Sildenafil In Healthy Adult Subjects [Abstract] American Journal of Respiratory and Critical Care Medicine 2010 A3331 ST-Effect On Peripheral Blood Pressure Of","DOI":"10.1164\/ajrccm-conference.2010.181.1_MeetingAbstracts.A3331"},{"key":"10.1002\/14651858.CD003825.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"2120-6 ST - A r","DOI":"10.1093\/ndt\/gfl133","article-title":"A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients","volume":"21","author":"Dussol","year":"2006","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003825.pub3-BIB21|cit21","first-page":"92","article-title":"Tienilic acid in the treatment fo hypertension. Double blind assessment of tienilic acid in essential hypertension","volume":"55","author":"Fried","year":"1979","journal-title":"Postgraduate Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD003825.pub3-BIB22|cit22","first-page":"159","article-title":"Diuretic therapy for mild hypertension: A comparison of the meatbolic effects of etozoline and chlorthalidone during long term treatment","volume":"50","author":"Galleti","year":"1991","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD003825.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"139-47 ST - Dos","DOI":"10.1111\/j.1365-2710.2006.00606.x","article-title":"Dosage dependent hormonal counter regulation to combination therapy in patients with left ventricular dysfunction","volume":"31","author":"Galloe","year":"2006","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD003825.pub3-BIB24|cit24","first-page":"468","article-title":"Pirenbtanide (HOE118): A new diuretic in essential hypertension","volume":"30","author":"Gupta","year":"1981","journal-title":"Current therapeutic reaserch"},{"key":"10.1002\/14651858.CD003825.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"746-52 ST - The","DOI":"10.1093\/eurjhf\/hfq090","article-title":"The effects of adding torasemide to standard therapy on peak oxygen consumption, natriuretic peptides, and quality of life in patients with compensated left ventricular systolic dysfunction","volume":"12","author":"Gupta","year":"2010","journal-title":"European Journal of Heart Failure"},{"key":"10.1002\/14651858.CD003825.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/j.1552-4604.1998.tb04470.x","article-title":"A randomized placebo controlled study of loop diuretics in patients with essential hypertension: teh Bumetanide and furosemide on lipid profile (BUFUL) clinical study report","volume":"38","author":"Heijden","year":"1998","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD003825.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/archinte.1979.03630490029011","article-title":"Role of renin classification for diuretic treatment of black hypertensive patients","volume":"139","author":"Holland","year":"1979","journal-title":"Arch Internal medicine"},{"key":"10.1002\/14651858.CD003825.pub3-BIB28|cit28","first-page":"792-6 ST - [Eff","article-title":"[Efficacy of monotherapy with 15 antihypertensive agents in treating essential hypertension assessed by 24-hour ambulatory blood pressure monitoring]","volume":"29","author":"Hua","year":"2007","journal-title":"Chung-Kuo i Hsueh Ko Hsueh Yuan Hsueh Pao Acta Academiae Medicinae Sinicae"},{"key":"10.1002\/14651858.CD003825.pub3-BIB29|cit29","doi-asserted-by":"crossref","unstructured":"Iyalomhe G B S Omogbai E K I Ozolua R I Antihypertensive and some biochemical effects of hydrochlorothiazide and furosemide in some Nigerians Journal of Medical Sciences 2007 977-83 ST - Antihypertensive and some biochemical","DOI":"10.3923\/jms.2007.977.983"},{"issue":"IV","key":"10.1002\/14651858.CD003825.pub3-BIB30|cit30","first-page":"125","article-title":"Dosage study of ciclretanine in elderly hypertensive patients: comparison of 50 vs 100mg daily dose","volume":"82","author":"Jungers","year":"1989","journal-title":"Arch Mal Coeur"},{"issue":"3","key":"10.1002\/14651858.CD003825.pub3-BIB31|cit31","first-page":"281","article-title":"Clinical experience with a fixed dose combination of penbutolol and furosemide in hypertension","volume":"31","author":"Knobem","year":"1982","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD003825.pub3-BIB32|cit32","first-page":"1194","article-title":"The antihypertensive effect of etozolin","volume":"22","author":"Kopp","year":"1978","journal-title":"Fortschr. Med.96.jg."},{"key":"10.1002\/14651858.CD003825.pub3-BIB33|cit33","first-page":"110","article-title":"Clinical and hemodynamic effects of high doses of slow release furosemide in arterial hypertension. A double blind cross over study with cyclopenthiazide","volume":"602","author":"Krogsgaard","year":"1976","journal-title":"Acta Med Scand Suppl"},{"issue":"10","key":"10.1002\/14651858.CD003825.pub3-BIB34|cit34","first-page":"349","article-title":"A randomized double blind clinical trial of Xipamid and hydrochlorthiazide in essential hypertension","volume":"22","author":"Kumar","year":"1984","journal-title":"International Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD003825.pub3-BIB35|cit35","unstructured":"Kundu S C Bhattacharya Td Vakil H B Diurnal pattern of blood pressure response to furosemide Indian Practitioner 1986 757-65 ST - Diurnal pattern of blood pressure res"},{"key":"10.1002\/14651858.CD003825.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3143\/geriatrics.22.346","article-title":"Comparison of clinical usefullness of diuretics in elderly and younger essentila hypertension - Double blind trial using tripamide","volume":"22","author":"Kuramoto","year":"1985","journal-title":"Jpn J Geriat"},{"key":"10.1002\/14651858.CD003825.pub3-BIB37|cit37","doi-asserted-by":"crossref","unstructured":"Laffi G Marra F Buzzelli G Azzena G Meacci E De Feo M L Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study Hepatology (Baltimore, Md.) 1991 1101-5 ST - Comparison of the effects of torasemi","DOI":"10.1002\/hep.1840130616"},{"key":"10.1002\/14651858.CD003825.pub3-BIB38|cit38","doi-asserted-by":"crossref","unstructured":"Leitch A G Clancy L Flenley D C The effect of bendrofluazide and frusemide on the ventilatory response to carbon dioxide and hypoxia in normal man Clinical science and molecular medicine 1974 377-85 ST - The effect of bendrofluazide and frus","DOI":"10.1042\/cs0470377"},{"issue":"suppl 3A","key":"10.1002\/14651858.CD003825.pub3-BIB39|cit39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0002-9343(88)90205-7","article-title":"Effects of angiotensin and angiotensin blockade on coronary circulation and coronary reserve","volume":"84","author":"Magrini","year":"1988","journal-title":"The American Journal of medicine"},{"key":"10.1002\/14651858.CD003825.pub3-BIB40|cit40","first-page":"30-2 ST - A ran","article-title":"A randomised placebo controlled trial of loop diuretics in moderate\/severe pre-eclampsia, following delivery","volume":"17","author":"Matthews","year":"1997","journal-title":"Journal of Obstetrics & Gynaecology"},{"key":"10.1002\/14651858.CD003825.pub3-BIB41|cit41","first-page":"523-31 ST - Car","article-title":"Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure","volume":"2","author":"Mitrovic","year":"2009","journal-title":"Circulation: Heart Failure"},{"issue":"4","key":"10.1002\/14651858.CD003825.pub3-BIB42|cit42","first-page":"773","article-title":"Comparative double blind trial with long acting furosemide and chlorthalidone in the treatment of essential hypertension","volume":"85","author":"Miziara","year":"1982","journal-title":"Farmacologica Clinica"},{"key":"10.1002\/14651858.CD003825.pub3-BIB43|cit43","first-page":"157","article-title":"Acute antihypertensive, diuretic and metabolic effect of etozolin and chlorthalidone","volume":"33","author":"Nami","year":"1991","journal-title":"Pamnivera Med"},{"issue":"6","key":"10.1002\/14651858.CD003825.pub3-BIB44|cit44","first-page":"443","article-title":"Comparison of slow release frusemide and bendrofluazide in teh treatment of moderater hypertension in Kenyan Negroes.","volume":"21","author":"Obel","year":"1984","journal-title":"Clinical Trials Journal"},{"issue":"6","key":"10.1002\/14651858.CD003825.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/cpt1978236703","article-title":"Tricynafen and hydrochlorthiazide in hypertension","volume":"23","author":"Okun","journal-title":"Clin Pharmacol, Ther"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003825.pub3-BIB46|cit46","first-page":"103","article-title":"A double-blind study of tienilic acid with two year follow-up of patients with mild to moderate essential hypertension","volume":"55","author":"Okun","year":"1979","journal-title":"Postgrad Med J"},{"issue":"3","key":"10.1002\/14651858.CD003825.pub3-BIB47|cit47","first-page":"537","article-title":"Sustained release frusemide and blood glucose levels in diabetics","volume":"34","author":"Oli","year":"1983","journal-title":"Cuurent Therapeutic Research"},{"issue":"1","key":"10.1002\/14651858.CD003825.pub3-BIB48|cit48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00005344-198101000-00014","article-title":"Involvement of Kallikrein in the Antihypertensive Response to Furosemide in Essential Hypertension","volume":"3","author":"Olshan","year":"1981","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"8118","key":"10.1002\/14651858.CD003825.pub3-BIB49|cit49","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(79)91149-8","article-title":"Biochemical and haematological changes induced by tienilic acid combined with propranolol in essential hypertension","volume":"1","author":"Pearson","journal-title":"The Lancet"},{"issue":"3","key":"10.1002\/14651858.CD003825.pub3-BIB50|cit50","first-page":"115","article-title":"Propranolol and tienilic acid in essential hypertension","volume":"55","author":"Pearson","year":"1979","journal-title":"Postgraduate Medical Journal"},{"key":"10.1002\/14651858.CD003825.pub3-BIB51|cit51","first-page":"127","article-title":"Atenolol improves blood pressure control in patients taking captopril and frusemide","volume":"1","author":"Potter","year":"1987","journal-title":"Journal of Human Hypertension"},{"issue":"1","key":"10.1002\/14651858.CD003825.pub3-BIB52|cit52","first-page":"183","article-title":"Hydrochlorthiazide versus a non-diuretic dose of torasemide as once daily antihypertensive monopharmacotharapy in elderly patients. A randomized douible blind study.","volume":"8","author":"Reyes","year":"1990","journal-title":"Progress in Pharmacology and clinical Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD003825.pub3-BIB53|cit53","first-page":"492","article-title":"Adding muzolimine or triamterene to nifedipine: effect on blood pressure","volume":"48","author":"Ronchi","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD003825.pub3-BIB54|cit54","doi-asserted-by":"crossref","unstructured":"Rush M G Engelhardt B Parker R A Hazinski T A Double-blind, placebo-controlled trial of alternate-day furosemide therapy in infants with chronic bronchopulmonary dysplasia The Journal of pediatrics 1990 112-8 ST - Double-blind, placebo-controlled trial","DOI":"10.1016\/S0022-3476(05)82458-8"},{"key":"10.1002\/14651858.CD003825.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/0002-9149(88)90549-8","article-title":"Effect of intravenous enalaprilat in moderate and severe systemic hypertension","volume":"62","author":"Rutledge","year":"1988","journal-title":"The American Journal of Cardiology"},{"key":"10.1002\/14651858.CD003825.pub3-BIB56|cit56","doi-asserted-by":"crossref","first-page":"E216 ST-Effect","DOI":"10.1016\/S0735-1097(11)60216-7","article-title":"Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: An analysis from DOSE-AHF","volume":"1)","author":"Shah","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD003825.pub3-BIB57|cit57","first-page":"973-81 ST - A m","article-title":"A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction","volume":"17","author":"Udelson James","year":"2011","journal-title":"Journal of Cardiac Failure"},{"key":"10.1002\/14651858.CD003825.pub3-BIB58|cit58","first-page":"296","article-title":"Treatment of benign essential hypertension with frusemide in different doses","volume":"2","author":"Valmin","year":"1980","journal-title":"Pharmacotherapeutica"},{"key":"10.1002\/14651858.CD003825.pub3-BIB59|cit59","doi-asserted-by":"crossref","unstructured":"van Kraaij D J Jansen R W Sweep F C Hoefnagels W H Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function European Journal of Heart Failure 2003 47-53 ST - Neurohormonal effects of furosemide wi","DOI":"10.1016\/S1388-9842(02)00205-2"},{"key":"10.1002\/14651858.CD003825.pub3-BIB60|cit60","first-page":"121","article-title":"Atenolol or propanolol in hypertensive patients poorly controlled on captopril and frusemide","volume":"1","author":"Webster","year":"1987","journal-title":"Journal of Human Hypertension"},{"key":"10.1002\/14651858.CD003825.pub3-BIB61|cit61","unstructured":"Witchitz S Giudicelli J F El-Guedri H Kamoun A Chiche P [Diuretic and anti-hypertensive effects of indapalide. Comparison with furosemide] Therapie 1974 109-18 ST - [Diuretic and anti-hypertensive effec"},{"issue":"6","key":"10.1002\/14651858.CD003825.pub3-BIB62|cit62","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1185\/03007998709111109","article-title":"Efficacy of a fixed dose combination of 40mg penbutolol with 6 mg pirentanide in the treatment of mild to moderate hypertension: a double blind study against placebo","volume":"10","author":"Yasky","year":"1987","journal-title":"Curr. Med. Res. Opi."},{"issue":"9","key":"10.1002\/14651858.CD003825.pub3-BIB63|cit63","first-page":"607","article-title":"Efficacy of a low dose fixed combination of penbutolol and pirentanide in teh treatment of mild to moderate hypertension: a double blind study against placebo","volume":"4","author":"Yasky","year":"1986","journal-title":"Pharmatherapeutica"},{"key":"10.1002\/14651858.CD003825.pub3-BIB64|cit64","doi-asserted-by":"crossref","first-page":"1575-83 ST - Ef","DOI":"10.1093\/ndt\/gfq565","article-title":"Effect of furosemide on left ventricular mass in non-dialysis chronic kidney disease patients: a randomized controlled trial","volume":"26","author":"Zamboli","year":"2011","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD003825.pub3-BIB65|cit65","article-title":"Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension","author":"Heran","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003825.pub3-BIB66|cit66","article-title":"Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension","author":"Heran","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003825.pub3-BIB67|cit67","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0002-8703(83)90117-5","article-title":"Insights into intrarenal sites and mechanism of action of diuretic agents","volume":"106","author":"Materson","year":"1983","journal-title":"American heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD003825.pub3-BIB68|cit68","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007066.pub3","article-title":"Blood pressure lowering efficacy of renin inhibitors for primary hypertension","author":"Musini","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD003825.pub3-BIB69|cit69","doi-asserted-by":"crossref","first-page":"e5673","DOI":"10.1371\/journal.pone.0005673","article-title":"Factors affecting blood pressure variability: Lessons learned from two systematic reviews of randomized controlled trials\u00a0","volume":"4","author":"Musini","journal-title":"PLOS ONE"},{"key":"10.1002\/14651858.CD003825.pub3-BIB70|cit70","volume-title":"Diuretic agents: clinical physiology and pharmacology","author":"Seldin","year":"1997"},{"issue":"3","key":"10.1002\/14651858.CD003825.pub3-BIB71|cit71","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008161","article-title":"First-line drugs for hypertension","author":"Wright","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003825.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,5,22]],"date-time":"2015-05-22T00:00:00Z","timestamp":1432252800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003825.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T02:43:12Z","timestamp":1687660992000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003825.pub3"}},"subtitle":[],"editor":[{"given":"Vijaya M","family":"Musini","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,8,15]]},"references-count":71,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003825.pub3","relation":{},"subject":[],"published":{"date-parts":[[2012,8,15]]}}}